SCHEMBL20179255

SCHEMBL20179255

C=Cc1ccccc1Oc1ccc(C(=C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.49
HTT P42858 5/20 0.45
HPGD P15428 4/20 0.45
ALDH1A1 P00352 7/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.43
GAA P10253 2/20 0.42
KMT2A Q03164 3/20 0.42
MAPT P10636 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MAPK1 P28482 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 3/20 0.38
APEX1 P27695 1/20 0.38
CYP3A4 P08684 2/20 0.38
MEN1 O00255 1/20 0.38
MAP2K1 Q02750 1/20 0.38
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18656991 0.87 LMNA (0.45) LMNAHTTHPGDALDH1A1CYP1A2
SCHEMBL21583680 0.86 HPGD (0.55) LMNAHTTHPGDALDH1A1CYP1A2
SCHEMBL21581862 0.84 GAA (0.47) LMNAHTTHPGDALDH1A1CYP1A2
SCHEMBL20179347 0.84 GAA (0.47) LMNAHTTHPGDALDH1A1CYP1A2
SCHEMBL18656977 0.84 ALDH1A1 (0.46) LMNAHTTHPGDALDH1A1CYP1A2
SCHEMBL6033676 0.83 LMNA (0.63) LMNAHTTHPGDALDH1A1CYP1A2
SCHEMBL18657003 0.81 GAA (0.44) LMNAHTTHPGDALDH1A1CYP1A2
SCHEMBL12516805 0.80 ALDH1A1 (0.69) LMNAHTTHPGDALDH1A1CYP1A2
SCHEMBL30618855 0.79 LMNA (0.64) LMNAHTTHPGDALDH1A1CYP1A2
SCHEMBL298766 0.79 LMNA (0.64) LMNAHTTHPGDALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541773-B1 ASYMMETRICALLY SUBSTITUTED BIS-ALKENYL DIPHENYL ETHERS, THEIR PREPARATION AND USE EVONIK OPERATIONS GMBH (DE) 2020-05-13 EP disclosed
US-20190367652-A1 ASYMMETRICALLY SUBSTITUTED BIS-ALKENYL DIPHENYL ETHERS, THEIR PREPARATION AND USE EVONIK TECHNOCHEMIE GMBH (DE) 2019-12-05 US disclosed
WO-2018091253-A1 ASYMMETRICALLY SUBSTITUTED BIS-ALKENYL DIPHENYL ETHERS, THEIR PREPARATION AND USE EVONIK TECHNOCHEMIE GMBH (DE) 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190367652-A1 ASYMMETRICALLY SUBSTITUTED BIS-ALKENYL DIPHENYL ETHERS, THEIR PREPARATION AND USE ITGB3, C9, CBR3 LMNA 208/4885HTT 3281/4885HPGD 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.